एंटाकैपोन के इंटरैक्शन

हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें एंटाकैपोन (Comtan) के 67 इंटरैक्शन दर्ज हैं: 1 गंभीर, 13 मध्यम, 26 मामूली, और 27 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।

लेबल से लिए गए इंटरैक्शन

गंभीर इंटरैक्शन (1)

  • ट्रैनिलसाइप्रोमिनMAO इनहिबिटरगंभीर

    …Cyclobenzaprine Contraindicated a SS Dextromethorphan Contraindicated a SS; Psychosis, bizarre behavior Dopamine Contraindicated a HR Droperidol Use with caution d QT interval prolongation Entacapone Use with caution d HR Fentanyl Use with caution d SS Hydroxytryptophan Contraindicated a SS Levodopa Contraindicated a HR Lithium Use with caution d SS Meperidine Contraindicated… (ट्रैनिलसाइप्रोमिन लेबल, दवाओं के इंटरैक्शन)

मध्यम इंटरैक्शन (13)

  • अमैंटाडिनएंटीकोलिनर्जिकमध्यम

    …Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline and epinephrine,… (एंटाकैपोन लेबल, चेतावनियां)

  • आइसोप्रेनालिनबीटा-एड्रीनर्जिक एगोनिस्टमध्यम

    Drugs Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline… (एंटाकैपोन लेबल, चेतावनियां)

  • आर्टिकेन और एड्रेनालिनलोकल एनेस्थेटिकमध्यम

    Drugs Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline… (एंटाकैपोन लेबल, चेतावनियां)

  • एड्रेनालिनसिम्पैथोमिमेटिकमध्यम

    Drugs Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline… (एंटाकैपोन लेबल, चेतावनियां)

  • कार्बिडोपा और लेवोडोपाडोपामिनर्जिक दवामध्यम

    …Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline and epinephrine,… (एंटाकैपोन लेबल, चेतावनियां)

  • कार्बिडोपा, लेवोडोपा और एंटाकैपोनडोपामिनर्जिक दवामध्यम

    …Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline and epinephrine,… (एंटाकैपोन लेबल, चेतावनियां)

  • डोब्यूटामिनसिम्पैथोमिमेटिकमध्यम

    Therefore, drugs known to be metabolized by COMT, such as isoproterenol, epinephrine, norepinephrine, dopamine, dobutamine, alpha-methyldopa, apomorphine, isoetherine, and bitolterol should be administered with caution in patients receiving entacapone regardless of the route of administration (including inhalation), as their interaction may result in increased… (एंटाकैपोन लेबल, चेतावनियां)

  • प्रिलोकेन और एड्रेनालिनलोकल एनेस्थेटिकमध्यम

    Drugs Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline… (एंटाकैपोन लेबल, चेतावनियां)

  • ब्यूपिवाकेन और एड्रेनालिनलोकल एनेस्थेटिकमध्यम

    Drugs Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline… (एंटाकैपोन लेबल, चेतावनियां)

  • मिथाइलडोपाएंटीहाइपरटेंसिव (ब्लड प्रेशर की दवा)मध्यम

    Therefore, drugs known to be metabolized by COMT, such as isoproterenol, epinephrine, norepinephrine, dopamine, dobutamine, alpha-methyldopa, apomorphine, isoetherine, and bitolterol should be administered with caution in patients receiving entacapone regardless of the route of administration (including inhalation), as their interaction may result in increased… (एंटाकैपोन लेबल, चेतावनियां)

  • लिडोकेन और एड्रेनालिनलोकल एनेस्थेटिकमध्यम

    Drugs Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline… (एंटाकैपोन लेबल, चेतावनियां)

  • लेवोडोपाडोपामिनर्जिक दवामध्यम

    …Metabolized By Catechol-O-Methyltransferase (COMT) When a single 400 mg dose of entacapone was given with intravenous isoprenaline (isoproterenol) and epinephrine without coadministered levodopa and dopa decarboxylase inhibitor, the overall mean maximal changes in heart rate during infusion were about 50% and 80% higher than with placebo, for isoprenaline and epinephrine,… (एंटाकैपोन लेबल, चेतावनियां)

  • वारफेरिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मध्यम

    Nevertheless, cases of significantly increased INR in patients concomitantly using warfarin have been reported during the postapproval use of entacapone. (एंटाकैपोन लेबल, दवाओं के इंटरैक्शन)

मामूली ज़िक्र (26)

  • आइसोनियाज़िडएंटीबायोटिकमामूली

    It is theoretically possible, therefore, that the combination of Entacapone Tablets and a non-selective MAO inhibitor (e.g., phenelzine and tranylcypromine) would result in inhibition of the majority of the pathways responsible for normal catecholamine metabolism. (एंटाकैपोन लेबल, चेतावनियां)

  • एम्पीसिलिनपेनिसिलिन एंटीबायोटिकमामूली

    These include probenecid, cholestyramine, and some antibiotics (e.g., erythromycin, rifampicin, ampicillin, and chloramphenicol). (एंटाकैपोन लेबल, सावधानियां)

  • एम्पीसिलिन और सल्बैक्टमपेनिसिलिन एंटीबायोटिकमामूली

    These include probenecid, cholestyramine, and some antibiotics (e.g., erythromycin, rifampicin, ampicillin, and chloramphenicol). (एंटाकैपोन लेबल, सावधानियां)

  • एरिथ्रोमाइसिनमैक्रोलाइड एंटीबायोटिकमामूली

    These include probenecid, cholestyramine, and some antibiotics (e.g., erythromycin, rifampicin, ampicillin, and chloramphenicol). (एंटाकैपोन लेबल, सावधानियां)

  • एस्पिरिनNSAIDमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • एस्पिरिन और डाइपिरिडामोलएंटीप्लेटलेट दवामामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • ऑर्फेनाड्रिन, एस्पिरिन और कैफीनमसल रिलैक्सेंटमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • कोलेस्टिरामिनबाइल एसिड सीक्वेस्ट्रेंटमामूली

    These include probenecid, cholestyramine, and some antibiotics (e.g., erythromycin, rifampicin, ampicillin, and chloramphenicol). (एंटाकैपोन लेबल, सावधानियां)

  • In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • डायज़ेपामबेंज़ोडायज़ेपिनमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • प्रोप्रानोलोलबीटा ब्लॉकरमामूली

    Treatment with propranolol was required. (एंटाकैपोन लेबल, चेतावनियां)

  • These include probenecid, cholestyramine, and some antibiotics (e.g., erythromycin, rifampicin, ampicillin, and chloramphenicol). (एंटाकैपोन लेबल, सावधानियां)

  • These include probenecid, cholestyramine, and some antibiotics (e.g., erythromycin, rifampicin, ampicillin, and chloramphenicol). (एंटाकैपोन लेबल, सावधानियां)

  • फेनेलज़िनMAO इनहिबिटरमामूली

    It is theoretically possible, therefore, that the combination of Entacapone Tablets and a non-selective MAO inhibitor (e.g., phenelzine and tranylcypromine) would result in inhibition of the majority of the pathways responsible for normal catecholamine metabolism. (एंटाकैपोन लेबल, चेतावनियां)

  • बाल्सालाज़ाइडसैलिसिलेटमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • बिस्मथ सबसैलिसिलेटसैलिसिलेटमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • ब्यूटाल्बिटल, एस्पिरिन और कैफीनबार्बिट्यूरेटमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • मिथाइलीन ब्लूMAO इनहिबिटरमामूली

    It is theoretically possible, therefore, that the combination of Entacapone Tablets and a non-selective MAO inhibitor (e.g., phenelzine and tranylcypromine) would result in inhibition of the majority of the pathways responsible for normal catecholamine metabolism. (एंटाकैपोन लेबल, चेतावनियां)

  • In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • मेसालामाइनसैलिसिलेटमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • रासाजिलिनMAO इनहिबिटरमामूली

    It is theoretically possible, therefore, that the combination of Entacapone Tablets and a non-selective MAO inhibitor (e.g., phenelzine and tranylcypromine) would result in inhibition of the majority of the pathways responsible for normal catecholamine metabolism. (एंटाकैपोन लेबल, चेतावनियां)

  • लिनेज़ोलिडएंटीबायोटिकमामूली

    It is theoretically possible, therefore, that the combination of Entacapone Tablets and a non-selective MAO inhibitor (e.g., phenelzine and tranylcypromine) would result in inhibition of the majority of the pathways responsible for normal catecholamine metabolism. (एंटाकैपोन लेबल, चेतावनियां)

  • सल्फासालाज़िनसल्फोनामाइडमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • साल्सालेटNSAIDमामूली

    In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam. (एंटाकैपोन लेबल, सावधानियां)

  • सेलेजिलिनMAO इनहिबिटरमामूली

    Entacapone can be taken concomitantly with a selective MAO-B inhibitor (e.g., selegiline). (एंटाकैपोन लेबल, चेतावनियां)

कोई महत्वपूर्ण इंटरैक्शन नहीं बताया गया (27)

  • इमिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • एमिट्रिप्टिलीनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • एमोक्सापिनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • एस्सिटालोप्रामSSRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • ओलैंज़ापिन और फ्लुओक्सेटिनएंटीसाइकोटिककोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • क्लोमिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • ट्राइमिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • ट्रैज़ोडोनएंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • डुलोक्सेटिनSNRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • डेसवेनलाफैक्सिनSNRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • डेसिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • डॉक्सेपिनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • नाल्ट्रेक्सोन और ब्यूप्रोपियॉनओपिओइड एंटागोनिस्टकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • नेफाज़ोडोनएंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • नॉरट्रिप्टिलीनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • पैरोक्सेटिनSSRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • प्रोट्रिप्टिलीनट्राइसाइक्लिक एंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • फ्लुओक्सेटिनSSRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • फ्लुवोक्सामिनSSRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • ब्यूप्रोपियॉनएंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • मिर्टाज़ापिनएंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • लेवोमिल्नासिप्रानSNRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • विलाज़ोडोनSSRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • वेनलाफैक्सिनSNRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • वोर्टियोक्सेटिनएंटीडिप्रेसेंटकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • सर्ट्रालिनSSRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

  • सिटालोप्रामSSRIकोई इंटरैक्शन नहीं

    No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa and dopa-decarboxylase inhibitor. (एंटाकैपोन लेबल, सावधानियां)

आप जो कुछ भी लेते हैं, उस सबके साथ एंटाकैपोन को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।

चेकर में खोलें

यह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।